AI-Driven Mitosis Profiling

Name: MitPro®: Advanced Mitosis Profiling
Brand: Histofy

MitPro®: the new wave of mitosis analysis

Counting mitotic figures, a crucial criterion for cancer grading, is inherently time-consuming and subject to significant inter-observer variability. MitPro® is an AI-driven solution for precise mitosis quantification and profiling, enhancing pathology workflows by increasing reliability, speed, and consistency of analysis.

Compatible with H&E whole-slide images (WSIs), MitPro® processes the entire slide, detects all mitotic figures, and identifies the three regions with the highest counts (hotspots). Pathologists can use these suggested hotspots or define their own custom regions for assessment.

‍This tool is currently for research use only and is undergoing CE-IVDR regulatory approval.

Microscopic view of pink-stained tissue cells with yellow squares highlighting clusters of dark nuclei.

Reduced time required for analysis

Significant time savings with AI-powered counting, as opposed to manual alternatives

Improved consistency in mitosis counting

AI-assisted mitosis counting leads to improved consistency between pathologists.

Supports a range of tumour types

Validated across breast, lung, melanoma, soft tissue sarcoma, leiomyoma, neuroendocrine tumours, glioblastoma, meningioma, thyroid, and retinoblastoma.

“Manual mitosis counting is essential but can be slow and inconsistent. MitPro^® ensures greater consistency between pathologists while significantly reducing the time required for assessment.”

—Prof David Snead, Chief Medical Officer, Histofy

Middle-aged man with glasses wearing a navy blazer and white shirt, smiling slightly in office setting.

AI-Driven Mitosis Profiling

MitPro®: the new wave of mitosis analysis

Reduced time required for analysis

Improved consistency in mitosis counting

Supports a range of tumour types

“Manual mitosis counting is essential but can be slow and inconsistent. MitPro^® ensures greater consistency between pathologists while significantly reducing the time required for assessment.”

Seamless integration with existing workflows

Accelerating the adoption of of AI-powered mitosis analysis

Histofy Releases MitPro for Next-Generation Mitosis Counting and Profiling

Histofy Joins Hands with Korean Partners to Develop Mitotic Figure Detection Device Powered by AI

Want to find out more?

AI-Driven Mitosis Profiling

MitPro®: the new wave of mitosis analysis

Reduced time required for analysis

Improved consistency in mitosis counting

Supports a range of tumour types

“Manual mitosis counting is essential but can be slow and inconsistent. MitPro® ensures greater consistency between pathologists while significantly reducing the time required for assessment.”

Seamless integration with existing workflows

Accelerating the adoption of of AI-powered mitosis analysis

Histofy Releases MitPro for Next-Generation Mitosis Counting and Profiling

Histofy Joins Hands with Korean Partners to Develop Mitotic Figure Detection Device Powered by AI

Want to find out more?

“Manual mitosis counting is essential but can be slow and inconsistent. MitPro^® ensures greater consistency between pathologists while significantly reducing the time required for assessment.”